medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2023, Number 3

<< Back

Rev Latin Infect Pediatr 2023; 36 (3)

Response to the clinical case: newborn with hepatosplenomegaly and exanthema

Language: Spanish
References: 12
Page: 143-146
PDF size: 123.14 Kb.





REFERENCES

  1. Wilson CB, Nizet V, Maldonado Y, Remington JS, Klein JO. Remington and Klein's infectious diseases of the fetus and newborn infant. 8th edition, Elsevier, 2016.

  2. Mavil L, De Silva E, Rubio M, Vera. Prevalencia de anticuerpos totales e IgM para citomegalovirus en población donadora zona norte del Valle de México. XXXI Jornada Annual de Agrupación Mexicana para el Estudio de la Hematología. 1991.

  3. Pesch M, Kunoushek K, McKee M y cols. Congenital cytomegalovirus infection clinical updates. BMJ. 2021; 373: n1212. doi: 10.1136/bmj.n1212.

  4. Luck SE, Wieringa JW, Blázquez-Gamero D y cols. Congenital cytomegalovirus: a european expert consensus statement on diagnosis and management. Pediatr Infect Dis J. 2017; 36 (12): 1205-1213.

  5. Satigeral P, Kourchenko H, Chacón JC, Salmerón G. Infección por Citomegalovirus. Infectología Neonatal. 2a edición. [ pre-print ].

  6. Gomila A, Rivas N, López E. Infección congénita por citomegalovirus. An Pediatr (Barc). 2008; 69

  7. Mehta V, Balachandran C, Lonikar V. Blueberry muffin baby: a pictoral differential diagnosis. Dermatol Online J. 2008; 14 (2): 8.

  8. Martins S, Rocha G, Silva G y cols. (2011). Bluebrry Muffin Baby, Apresentação Rara de Infecção Congénita por Citomegalovírus. Acta Med Port. 2011; 24 (S3): 703-708.

  9. Kaleta K, K?osowicz A, Ju?ko N, Kapiñska-Mrowiecka M. Blueberry muffin baby syndrome. A critical primary sign of systemic disease. Postepy Dermatol Alergol. 2022; 39 (2): 418-420.

  10. Palma S, Roversi MF, Bettini M, y cols. Hearing loss in children with congenital cytomegalovirus infection: an 11-year retrospective study based on laboratory database of a tertiary paediatric hospital. Acta Otorhinolaryngol Ital. 2019; 39 (1): 40-45.

  11. Kimberlin DW, Jester PM, Sánchez PJ, y cols. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015; 372 (10): 933-943.

  12. Plotkin SA, Wang D, Oualim A, y cols. The status of vaccine development against the human cytomegalovirus. J Infect Dis. 2020; 221 (Suppl 1): S113-S122.




2020     |     www.medigraphic.com